Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-11-000426

CHIEF EXECUTIVE OFFICER acquired 76,087 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award +76,087 $3.50 $266,305 76,087 I
Derivatives
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +10,000 10,000 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +10,000 10,000 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +11,250 11,250 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +500,000 500,000 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +212,500 212,500 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Warrant +750 750 D
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +10,000 10,000 I
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Stock Option (Right to Buy) +20,000 20,000 I
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Warrant +40,169 40,169 I
Singh Shawn CHIEF EXECUTIVE OFFICER 2011-05-11 Grant or award · Warrant +17,857 17,857 I
Loading xslF345X03/form4-05252011_030529.xml…